Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.
| Autor: | Lakey-Beitia, Johant, Burillo, Andrea M., La Penna, Giovanni, Hegde, Muralidhar L., Rao, K.S., Rao, K.S. Jagannatha, Britton, Gabrielle B., Rocha Arrieta, Luisa Lilia, Garcia-Cairasco, Norberto, Lazarowski, Alberto, Palacios, Adrián, Espuny, Antoni Camins, Maccioni, Ricardo B. |
|---|---|
| Předmět: |
METAL compounds
ALZHEIMER'S disease TRANSITION metal ions POLYPHENOLS PROTEIN precursors AMYLOID DEFEROXAMINE THERAPEUTIC use of antioxidants ZINC metabolism COPPER metabolism RESEARCH RESEARCH methodology CHELATING agents ANTIOXIDANTS MEDICAL cooperation EVALUATION research OXIDATIVE stress COMPARATIVE studies PEPTIDES PHARMACODYNAMICS CHEMICAL inhibitors |
| Zdroj: | Journal of Alzheimer's Disease; 2021 Supplement, Vol. 82, pS335-S357, 23p |
| Abstrakt: | Alzheimer's disease (AD) is the most common neurodegenerative disease affecting more than 50 million people worldwide. The pathology of this multifactorial disease is primarily characterized by the formation of amyloid-β (Aβ) aggregates; however, other etiological factors including metal dyshomeostasis, specifically copper (Cu), zinc (Zn), and iron (Fe), play critical role in disease progression. Because these transition metal ions are important for cellular function, their imbalance can cause oxidative stress that leads to cellular death and eventual cognitive decay. Importantly, these transition metal ions can interact with the amyloid-β protein precursor (AβPP) and Aβ42 peptide, affecting Aβ aggregation and increasing its neurotoxicity. Considering how metal dyshomeostasis may substantially contribute to AD, this review discusses polyphenols and the underlying chemical principles that may enable them to act as natural chelators. Furthermore, polyphenols have various therapeutic effects, including antioxidant activity, metal chelation, mitochondrial function, and anti-amyloidogenic activity. These combined therapeutic effects of polyphenols make them strong candidates for a moderate chelation-based therapy for AD. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|